Melinta Therapeutics, LLC et al v. Nexus Pharmaceuticals, Inc.
| Melinta Subsidiary Corp., Rempex Pharmaceuticals, Inc. and Melinta Therapeutics, LLC |
| Nexus Pharmaceuticals, Inc. |
| 1:2021cv02636 |
| May 14, 2021 |
| US District Court for the Northern District of Illinois |
| John F Kness |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 9, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 24 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18440661. (Chou, Monica) |
| Filing 23 REPLY by Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. to response in opposition to motion, #18 for 45-Day Extension to Local Patent Rule 2.1 Initial Disclosures (Hood, Gary) |
| Filing 22 MINUTE entry before the Honorable John F. Kness: Plaintiffs' Motion for leave to file document under seal #19 is granted. Mailed notice (ef, ) |
| Filing 21 REDACTED ANSWER to counterclaim OF DEFENDANT NEXUS PHARMACEUTICALS, INC. by Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc.(Anderson, Brian) |
| Filing 20 SEALED DOCUMENT by Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. PLAINTIFFS' ANSWER TO THE COUNTERCLAIMS OF DEFENDANT NEXUS PHARMACEUTICALS, INC. (Anderson, Brian) |
| Filing 19 MOTION by Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. for leave to file UNDER SEAL (Anderson, Brian) |
| Filing 18 RESPONSE by Nexus Pharmaceuticals, Inc.in Opposition to MOTION by Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. for extension of time for Exchange of Initial Disclosures under Local Patent Rule 2.1 #14 (Wallace, Joel) |
| Filing 17 MINUTE entry before the Honorable John F. Kness: By agreement of the parties, the Court sets the following briefing schedule on Plaintiffs' Opposed Motion For 45-Day Extension To Local Patent Rule 2.1 Initial Disclosures #14 : Defendant must respond on or before 6/21/2021 and Plaintiffs must reply on or before 6/28/2021. Within one week of filing, each side must provide two paper courtesy copies of their respective briefs to chambers via U.S. Mail or reliable commercial delivery service. Mailed notice (ef, ) |
| Filing 16 PROPOSED BRIEFING SCHEDULE FOR PLAINTIFFS' OPPOSED MOTION FOR 45-DAY EXTENSION TO LOCAL PATENT RULE 2.1 INITIAL DISCLOSURES STATEMENT by Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. (Hood, Gary) |
| Filing 15 ATTORNEY Appearance for Counter Claimant Nexus Pharmaceuticals, Inc., Defendant Nexus Pharmaceuticals, Inc. by Imron T Aly (Aly, Imron) |
| Filing 14 MOTION by Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. for extension of time for Exchange of Initial Disclosures under Local Patent Rule 2.1 (Hood, Gary) |
| Filing 13 ATTORNEY Appearance for Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. by Brian Neil Anderson (Anderson, Brian) |
| Filing 12 MINUTE entry before the Honorable John F. Kness: Defendant's Motion to for leave to file under seal document #11 is granted. Mailed notice (ef, ) |
| Filing 11 MOTION by Counter Claimant Nexus Pharmaceuticals, Inc., Defendant Nexus Pharmaceuticals, Inc. to seal document sealed document #9 (Wallace, Joel) |
| Filing 10 REDACTED ANSWER to Complaint , Affirmative Defenses, and COUNTERCLAIM filed by Nexus Pharmaceuticals, Inc. against All Plaintiffs . by Nexus Pharmaceuticals, Inc.(Wallace, Joel) |
| Filing 9 SEALED DOCUMENT by Defendant Nexus Pharmaceuticals, Inc. Answer, Affirmative Defenses, and Counterclaims (Wallace, Joel) |
| Filing 8 ATTORNEY Appearance for Defendant Nexus Pharmaceuticals, Inc. by Joel M Wallace (Wallace, Joel) |
| Filing 7 MAILED patent report to Patent Trademark Office, Alexandria VA (exr, ) |
| CASE ASSIGNED to the Honorable John F. Kness. Designated as Magistrate Judge the Honorable Maria Valdez. Case assignment: Random assignment. (mp, ) |
| Filing 6 Notice of Claims Involving Patents under Local Rule 3.4 by Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. (Hood, Gary) |
| Filing 5 ATTORNEY Appearance for Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. by Mark Thomas Deming (Deming, Mark) |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by All Plaintiffs (Hood, Gary) |
| Filing 3 ATTORNEY Appearance for Plaintiffs Melinta Subsidiary Corp., Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc. by Gary Edward Hood (Hood, Gary) |
| Filing 2 CIVIL Cover Sheet (Hood, Gary) |
| Filing 1 COMPLAINT filed by Melinta Therapeutics, LLC, Rempex Pharmaceuticals, Inc., Melinta Subsidiary Corp.; Filing fee $ 402, receipt number 0752-18250241. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Hood, Gary) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
